Viewing Study NCT04300803


Ignite Creation Date: 2025-12-24 @ 7:49 PM
Ignite Modification Date: 2025-12-25 @ 5:26 PM
Study NCT ID: NCT04300803
Status: APPROVED_FOR_MARKETING
Last Update Posted: 2020-08-28
First Post: 2020-03-05
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Expanded Access Program for Tafasitamab (MOR00208) in R/R DLBCL
Sponsor: MorphoSys AG
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Eligibility Module